Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Despite tremendous efforts in the search for safe, efficacious and non-addictive opioids for pain treatment, morphine remains the most valuable painkiller in contemporary medicine. Opioids exert their pharmacological actions through three opioid-receptor classes, mu, delta and kappa, whose genes have been cloned. Genetic approaches are now available to delineate the contribution of each receptor in opioid function in vivo. Here we disrupt the mu-opioid-receptor gene in mice by homologous recombination and find that there are no overt behavioural abnormalities or major compensatory changes within the opioid system in these animals. Investigation of the behavioural effects of morphine reveals that a lack of mu receptors abolishes the analgesic effect of morphine, as well as place-preference activity and physical dependence. We observed no behavioural responses related to delta- or kappa-receptor activation with morphine, although these receptors are present and bind opioid ligands. We conclude that the mu-opioid-receptor gene product is the molecular target of morphine in vivo and that it is a mandatory component of the opioid system for morphine action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, in animal models, dopamine D1 receptor knockout rats will not self-administer cocaine37 and μ opioid receptor knockout mice will not show the rewarding effects of opioids.153”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [153]
In the citing paper
“Mice that lack the MOR gene do not develop place preferences or withdrawal symptoms in response to morphine (Matthes et al 1996).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Matthes et al 1996
Citations
Cites
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationNeutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Roques, B. P., Noble, F., Daugé, V, Fournié-Zaluski, M. C., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 756
Self-citationLufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationChiara, G. D., & Alan North, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90062-b · Cited by 543
Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M., & Nestler, E. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91111-d · Cited by 535
A brief history of opiates, opioid peptides, and opioid receptors.
Brownstein, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5391 · Cited by 491
Multiple opioid receptors: ligand selectivity profiles and binding site signatures.
Goldstein, A., & Naidu, A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09190-4 · Cited by 445
Kieffer, B. L. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071128 · Cited by 389
Self-citationReduction of Morphine Abstinence in Mice with a Mutation in the Gene Encoding CREB
Maldonado, R., Blendy, J. A., Tzavara, E., Gass, P., Roques, B. P., Hanoune, J., & Schütz, G. (1996) · Science · doi:10.1126/science.273.5275.657 · Cited by 292
Self-citationThe mouse Pgk-1 gene promoter contains an upstream activator sequence
McBurney, M. W., Sutherland, L. C., Adra, C. N., Leclair, B., Rudnicki, M. A., & Jardine, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5755 · Cited by 193
Research works printed but not linked: 9
- Goldstein, A. & Naidu, A. Mol. Pharmacol. 36, 265–272 (1989).
- Pasternak, G. W. Clin. Pharmacol. 16, 1–18 (1993).
- Cowan, A. in Handbook of Experimental Pharmacology Opioids II (ed. Herz, A.) Vol. 104, 393–414 (Springer, Berlin, 1993).
- Roques, B. P., Noble, F., Daugé, V., Fournié-Zaluski, M.-C. & Beaumont, A. Pharmacol. Rev. 45, 87–146 (1993).
- Baamonde, A., Daugé, V., Gacel, C. & Roques, B. P. J. Pharmacol. Exp. Ther. 257, 767–773 (1991).
- Koob, G. F. Trends Biochem. Sci. 13, 177–184 (1992).
- Wei, E. T. J. Pharmacol. Exp. Ther. 216, 12–18 (1981).
- Cowan, A., Zhu, X. Z., Mosberg, H. I., Omnaas, J. R. & Porreca, F. J. Pharmacol. Exp. Ther. 246, 950–955 (1988).
- Kitchen, I. et al. J. Pharmacol. Exp. Ther. 275, 1595–1607 (1995).
Cited by
Items 701–800 of 1,002
Lack of the nociceptin receptor does not affect acute or chronic nociception in mice
Bertorelli, R., Bastia, E., Citterio, F., Corradini, L., Forlani, A., & Ongini, E. (2002) · Peptides · doi:10.1016/s0196-9781(02)00102-x · Cited by 36
Merrer, J. L., Gavello-Baudy, S., Galey, D., & Cazala, P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.014 · Cited by 41
Goodchild, C. S., Nadeson, R., & Cohen, E. (2004) · European Journal of Anaesthesiology · doi:10.1017/s0265021504003035 · Cited by 36
Ikeda, K., Kobayashi, T., Ichikawa, T., Kumanishi, T., Niki, H., & Yano, R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01334.2001 · Cited by 39
“Mice that lack the m-OR gene (m-OR-KO) are insensitive to morphine (Matthes et al., 1996; Sora et al., 1997b; Tian et al., 1997; Loh et al., 1998) and are less sensitive to d- and k-agonists (Sora et al., 1997a, 1999; Matthes et al., 1998) despite a normal expression of d- and k-opioid receptors in…”
DiPirro, J. M., & Kristal, M. B. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.006 · Cited by 36
Noble, F., Szűcs, M., Kieffer, B. L., & Roques, B. P. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12152-9 · Cited by 39
Self-citationHyperactivity and dopamine D 1 receptor activation in mice lacking girk2 channels
Blednov, Y. A., Stoffel, M., Cooper, R., Wallace, D., Mane, N., & Harris, R. A. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0937-6 · Cited by 36
Hu, X., Bi, J., Loh, H. H., & Wei, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005477200 · Cited by 35
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat
Cox, M. L., & Welch, S. P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.022 · Cited by 35
The Cholinergic System as a Treatment Target for Opioid Use Disorder
Jensen, K. P., DeVito, E. E., Yip, S. W., Carroll, K. M., & Sofuoglu, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0572-y · Cited by 38
“For example, unlike wild-type mice, MOR gene knockout mice do not show preference for morphine in a conditioned place preference task, do not self-administer morphine or heroin, and do not show signs of opioid withdrawal following chronic opioid exposure [46, 47].”
Emery, M. A., & Eitan, S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.010 · Cited by 38
“Genetic knockout of the MOR in mice results in a loss of morphine-induced analgesia, a loss of morphine reward, and a loss of withdrawal symptoms following chronic exposure to morphine (Matthes et al., 1996).”
Emerging Insights into Mu Opioid Pharmacology
Pasternak, G. W., Childers, S. R., & Pan, Y. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_270 · Cited by 37
Pharmacogenetics of morphine: Potential implications in sickle cell disease
Darbari, D. S., Minniti, C. P., RANA, S. R., & van den Anker, J. N. (2007) · American Journal of Hematology · doi:10.1002/ajh.21027 · Cited by 35
Kahveci, N., Süyen, G. G., & Özlük, K. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.11.023 · Cited by 36
Functional Interactions between Opioid and 2A -Adrenergic Receptors
Jordan, B. A., Gomes, I., Rios, C., Filipovska, J., & Devi, L. A. (2003) · Cited by 35
Impaired water maze learning performance in μ-opioid receptor knockout mice
Jang, C., Lee, S., Yoo, J., Yan, J.-J., Song, D., Loh, H. H., & Ho, I. K. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00291-2 · Cited by 43
Greenwald, M. K., & Stitzer, M. L. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00104-5 · Cited by 35
Opioid Agonists and Antagonists
Ogura, T., & Egan, T. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1679-5.00015-6 · Cited by 35
Zhang, C. P., Chen, X., Zhang, X., Li, W., Miao, X., & Zhou, Q.-H. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2026.09.002 · Cited by 35
RetractedMcPherson, K. B., Leff, E. R., Li, M.-H., Meurice, C., Tai, S., Traynor, J. R., & Ingram, S. L. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0516-18.2018 · Cited by 34
“Morphine and other opioids elicit antinociception through the activation of a specific set of G-protein-coupled receptors (GPCRs)—the -opioid receptors (Matthes et al., 1996).”
BackgroundThe sigma‐1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors
Ruiz‐Cantero, M. C., Cortés‐Montero, E., Jain, A., Montilla‐García, Á., Bravo‐Caparrós, I., Shim, J., Sánchez‐Blázquez, P., Woolf, C. J., Baeyens, J. M., & Cobos, E. J. (2022) · British Journal of Pharmacology · doi:10.1111/bph.16003 · Cited by 35
“Although it seems evident to attribute the effect of morphine to direct actions on the μ receptor (Matthes et al., 1996), S1RA or BD-1063 lack any affinity for the μ receptor (Sánchez-Fernández et al., 2013).”
BackgroundHahn, Y. K., Paris, J. J., Lichtman, A. H., Hauser, K. F., Sim‐Selley, L. J., Selley, D. E., & Knapp, P. E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.014 · Cited by 37
Zhang, M., Wang, K., Ma, M., Tian, S., Wei, N., & Wang, G. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001129 · Cited by 33
Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease
Xu, C., Liu, G., Ji, H., Chen, W., Dai, D., Chen, Z., Zhou, D., Xu, L., Hu, H., Cui, W., et al. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9424 · Cited by 38
“for its neuropharmacological effects (10).”
Replacement of current opioid drugs focusing on MOR-related strategies
Busserolles, J., Lolignier, S., Kerckhove, N., Bertin, C., Authier, N., & Eschalier, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107519 · Cited by 38
Yoo, J. H., Kitchen, I., & Bailey, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01952.x · Cited by 38
“The use of MOPr KO mice clearly demonstrated that the MOPr is the primary molecular target for morphine as morphine CPP (Matthes et al., 1996; Sora et al., 2001; Mizoguchi et al., 2003) and self-administration (Becker et al., 2000) were completely abolished in KO animals.”
BackgroundSelf-citationMorphine-Induced Reduction of Intraocular Pressure and Pupil Diameter: Role of Nitric Oxide
Dortch‐Carnes, J., & Russell, K. R. M. (2006) · Pharmacology · doi:10.1159/000091993 · Cited by 34
“The present study has provided, for the first time, evidence of the role of NO in the ocular hypotensive and miotic effects of morphine. Morphine is known to mediate its effects through activation of μ opioid receptors [”
BackgroundEnhanced humoral response in kappa-opioid receptor knockout mice
Gavériaux‐Ruff, C., Simonin, F., Filliol, D., & Kieffer, B. L. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00419-8 · Cited by 34
Self-citationAnalgesic Tone Conferred by Constitutively Active Mu Opioid Receptors in Mice Lacking β-Arrestin 2
Lam, H. A., Maga, M., Pradhan, A. A. A., Evans, C. J., Maidment, N. T., Hales, T. G., & Walwyn, W. M. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-24 · Cited by 34
“Mice lacking b-arr2 exhibit unaltered naloxone conditioned place aversion In addition to nociception, μ receptors regulate reward and hedonic tone [23, 32 ].”
BackgroundInfluentialCross-talk between metabolism and reproduction: the role of POMC and SF1 neurons
Xu, Y., Faulkner, L. D., & Hill, J. W. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00098 · Cited by 37
“…enkephalin, and endorphin; Konig et al., 1996; Rubinstein et al., 1996; Sharifi et al., 2001) as well as mutants of the three opioid receptors (Matthes et al., 1996; Sora et al., 1997; Roy et al., 1998; Simonin et al., 1998; Schuller et al., 1999; Zhu et al., 1999; Filliol et al., 2000) are…”
BackgroundDisease-Specific Heteromerization of G-Protein-Coupled Receptors That Target Drugs of Abuse
Gomes, I., Fujita, W., Chandrakala, M. V., & Devi, L. A. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386931-9.00009-x · Cited by 39
Wang, H., Chang, W., Hsu, C., Huang, P., Chow, Y., & Li, A. H.-L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01114-0 · Cited by 34
Transcriptional Regulation of μ Opioid Receptor Gene by cAMP Pathway
Lee, P.-W., & Lee, Y.-M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1410 · Cited by 39
“The critical role of MOR in analgesia, as well as in the development of tolerance and dependence, has been further confirmed by the analysis of knockout mice in which this receptor has been eliminated (Matthes et al., 1996; Sora et al., 1997).”
Cheng, H. M., Laviolette, S. R., van der Kooy, D., & Penninger, J. M. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03435.x · Cited by 35
McLeman, E. R., Warsh, J. J., Ang, L. C., Li, P. P., Kalasinsky, K. S., Ross, B. M., Tong, J., Schmunk, G. A., Adams, V. I., & Kish, S. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742120.x · Cited by 36
Andria, M. L., & Simon, E. J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00126-6 · Cited by 34
Baldo, B. A., & Pham, N. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7261-2_8 · Cited by 33
Duraffourd, C., Kumala, E., Anselmi, L., Brecha, N., & Sternini, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110230 · Cited by 31
The Emerging Perspective of Morphine Tolerance: MicroRNAs
Zhang, T.-J., Qiu, Y., & Hua, Z. (2019) · Pain Research and Management · doi:10.1155/2019/9432965 · Cited by 33
Opioid treatment for acute and chronic pain in patients with sickle cell disease
Carroll, C. P. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134534 · Cited by 36
Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?
Rawas, R. E., Amaral, I. M., & Hofer, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144833 · Cited by 33
Mavrikaki, M., Lintz, T., Constantino, N. J., Page, S., & Chartoff, E. H. (2020) · Addiction Biology · doi:10.1111/adb.12973 · Cited by 39
Costa, F. V., Rosemberg, D. B., Rosa, L. V., de Quadros, V. A., de Abreu, M. S., Santos, A. R. S., Sneddon, L. U., & Kalueff, A. V. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210311104408 · Cited by 35
Nicotine and opioid co-dependence: Findings from bench research to clinical trials
Custodio-Patsey, L., Malone, S. G., Bardo, M. T., & Turner, J. R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.030 · Cited by 39
Zhou, L., Stahl, E. L., Lovell, K. M., Frankowski, K. J., Prisinzano, T. E., Aubé, J., & Bohn, L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.001 · Cited by 37
“In the MOR-KO mouse brain, the KOR and DOR receptor densities have been reported to remain unchanged and KOR-mediated G protein coupling was previously shown to be preserved (Matthes et al., 1996; Park et al., 2000).”
In Vivo Regulation of the μ Opioid Receptor: Role of the Endogenous Opioid Agents
González-Núñez, V., Jiménez-González, A., Barreto-Valer, K., & Rodríguez, R. E. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00318 · Cited by 34
“In contrast, no changes in penk or pomc expression were seen in μ-deficient knockout mice (7).”
BackgroundCharacterization of the 3′ untranslated region of the human mu-opioid receptor (MOR-1) mRNA
Ide, S., Han, W., Kasai, S., Hata, H., Sora, I., & Ikeda, K. (2005) · Gene · doi:10.1016/j.gene.2005.05.040 · Cited by 33
Joshi, S. K., Mikusa, J. P., Weaver, B., & Honoré, P. (2007) · Journal of Pain · doi:10.1016/j.jpain.2007.09.004 · Cited by 33
Candidate gene polymorphisms predicting individual sensitivity to opioids
Kasai, S., Hayashida, M., Sora, I., & Ikeda, K. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0205-3 · Cited by 38
“For example, morphine-induced analgesia is abolished in MOP knockout mice (Matthes et al. 1996; Sora et al. 1997; Loh et al. 1998).”
BackgroundMu opioid receptor knockout mice in the Morris Water Maze: A learning or motivation deficit?
Lubbers, M. E., VANDENBOS, R., & Spruijt, B. M. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.021 · Cited by 34
Torres-Reverón, A., Khalid, S., Williams, T. J., Waters, E. M., Drake, C. T., McEwen, B. S., & Milner, T. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.058 · Cited by 35
“Morphine and other addictive opiates can produce their addictive actions by activating µ opioid receptors (Matthes et al., 1996).”
BackgroundPharmacogenomics and addiction to opiates
Lichtermann, D., Franke, P. E., Maier, W., & Rao, M. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00820-7 · Cited by 38
Gouardères, C., Faura, C. C., & Zajac, J. ‐. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.005 · Cited by 33
Genetics of alcohol and other abused drugs
Crabbe, J. C., & Phillips, T. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00066-0 · Cited by 31
Gamble, M. C., Williams, B. R., Singh, N., Posa, L., Freyberg, Z., Logan, R. W., & Puig, S. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1059089 · Cited by 36
“Prescription opioids specifically modulate analgesia through MOR (Matthes et al., 1996; Loh et al., 1998), which is concentrated in structures essential for conductance of pain-related signaling including peripheral sensory neurons, spinal cord, brainstem and central brain nuclei (Mansour et al.”
BackgroundMarrone, G. F., Grinnell, S. G., Lu, Z., Rossi, G. C., Rouzic, V. L., Xu, J., Majumdar, S., Pan, Y., & Pasternak, G. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523894113 · Cited by 32
Kappa opioid receptor signaling protects cartilage tissue against posttraumatic degeneration
Wu, L., Zhang, S., Shkhyan, R., Lee, S., Gullo, F., Eliasberg, C. D., Petrigliano, F. A., Ba, K., Wang, J., Lin, Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.88553 · Cited by 33
Bull, F. A., Baptista‐Hon, D. T., Lambert, J. J., Walwyn, W. M., & Hales, T. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10360-8 · Cited by 34
Usefulness of knockout mice to clarify the role of the opioid system in chronic pain
Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14088 · Cited by 39
“…MOP constitutive knockout mice have been obtained by disruption of exon 1 (Sora et al., 1997; Tian et al., 1997; Schuller et al., 1999), exon 2 (Matthes et al., 1996), exon 2 and 3 (Loh et al., 1998; van Rijn and Whistler, 2009) or exon 11 (Pan et al., 2009) of the Oprm1 gene in mice with…”
BackgroundSelf-citationPotential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review
Kaski, S. W., White, A., Gross, J., & Siderovski, D. P. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005309 · Cited by 32
Kögel, B. Y., Vry, J. D., Tzschentke, T., & Christoph, T. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.014 · Cited by 32
Stefano, G. B., Kream, R. M., Mantione, K. J., Sheehan, M., Cadet, P., Zhu, W. M., Bilfinger, T. V., & Esch, T. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.12.003 · Cited by 36
Lutz, P. E., Reiss, D., Ouagazzal, A. M., & Kieffer, B. L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.049 · Cited by 32
“Numerous data document the crucial regulation of social behaviours by the mu opioid receptor, the molecular target of morphine [37], across various developmental stages and species.”
BackgroundSelf-citationμ-Opioid receptor activation prevents acute hepatic inflammation and cell death
Chakass, D. N., Philippe, D., Erdual, E., Dharancy, S., Body–Malapel, M., Dubuquoy, C., Thuru, X., Gay, J., Gavériaux‐Ruff, C., Dubus, P. R., et al. (2007) · Gut · doi:10.1136/gut.2006.105122 · Cited by 35
Self-citationCraving for Alcohol and Drugs in Animals and Humans: Biology and Behavior
Miller, N. S., & Goldsmith, R. J. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_08 · Cited by 37
Noble, F., Benturquia, N., Bilkei‐Gorzó, A., Zimmer, A., & Roques, B. P. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0964-z · Cited by 35
“Moreover, it has been shown that the mu receptor is critically involved in the control of nociception (Matthes et al. 1996), whereas the delta seems to be implicated in emotional control (Calenco-Choukroun et al.”
BackgroundSelf-citationGfi-1 takes center stage in hematopoietic stem cells
Duan, Z., & Horwitz, M. S. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.003 · Cited by 39
Sitbon, P., Elstraete, A. C. V., Hamdi, L., Juarez‐Perez, V., Mazoit, J., Benhamou, D., & Rougeot, C. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001320 · Cited by 35
Fluorescently Labeled Morphine Derivatives for Bioimaging Studies
Lam, R., Gondin, A. B., Canals, M., Kellam, B., Briddon, S. J., Graham, B., & Scammells, P. J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01811 · Cited by 32
Deletion of the mu opioid receptor results in impaired acquisition of Pavlovian context fear
Sanders, M. J., Kieffer, B. L., & Fanselow, M. S. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.03.001 · Cited by 34
“The initial production of the line has been described previously (Matthes et al., 1996).”
BackgroundMethodSelf-citationAnzini, M., Canullo, L., Braile, C., Cappelli, A., Gallelli, A., Vomero, S., Menziani, M. C., Benedetti, P. G. D., Rizzo, M., Collina, S., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0307640 · Cited by 37
“These experimental results are in agreement with previous data reporting that the -opioid agonist dynorphin A-(1-13) reverts the scopolamine- and pirenzepineinduced memory impairment of step-down type passive avoidance response and spontaneous alternation performance.37 Dynorphin A-( 1-13 ) also reduces the amnesia in…”
BackgroundResultBlanchet, C., Sollini, M., & Lüscher, C. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00173-8 · Cited by 35
“The induction of dependence needs the activation of -opioid receptors (MORs), as mice with the targeted disruption of this receptor do not show any withdrawal syndrome when challenged with naloxone after chronic morphine administration (Matthes et al., 1996).”
BackgroundBailey, A., Matthes, H. W. D., Kieffer, B. L., Slowe, S. J., Hourani, S. M. O., & Kitchen, I. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02536-2 · Cited by 32
Self-citationWang, H. L. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00174-4 · Cited by 32
Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese subjects
Li, T., Liu, X., Zhu, Z. H., Zhao, J., Hu, X., Sham, P. C., & Collier, D. A. (2000) · Addiction Biology · doi:10.1080/13556210050003775 · Cited by 33
Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
Rallis, E. A., Nasiopoulou, A., KOUSKOUKIS, C. E., & Koumantaki, E. (2004) · PubMed · Cited by 34
Opiate-Induced Analgesia: Contributions From Mu, Delta and Kappa Opioid Receptors Mouse Mutants
Gavériaux‐Ruff, C. (2014) · Current Pharmaceutical Design · doi:10.2174/138161281942140105163727 · Cited by 32
Bednarczyk–Cwynar, B., Wachowiak, N., Szulc, M., Kamińska, E., Bogacz, A., Bartkowiak-Wieczorek, J., Zaprutko, L., & Mikołajczak, P. Ł. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00202 · Cited by 31
Yang, J., Reilly, B. G., Davis, T. P., & Ronaldson, P. T. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040192 · Cited by 33
“For example, mice lacking the μ-opioid receptor show no overt behavioral abnormalities or compensatory changes in the opioid system; however, these animals do not experience analgesia, place-preference activity, or physical dependence when administered morphine [30].”
BackgroundLi, H., Su, W., Shu, Y., Yuan, X.-C., Lin, L.-X., Hou, T., Xiang, H.-C., Zhu, H., Hu, X.-F., Li, P., et al. (2019) · Journal of Pain Research · doi:10.2147/jpr.s191900 · Cited by 31
Ruegsegger, G. N., Toedebusch, R. G., Will, M. J., & Booth, F. W. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.022 · Cited by 33
“While substantial evidence suggests endogenous opioid signaling in the NAc regulates behavior associated with both drug (Matthes et al., 1996) and natural rewards (Bakshi and Kelley, 1993; Will et al.”
BackgroundLupp, A., Richter, N., Doll, C., Nagel, F., & Schulz, S. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.09.004 · Cited by 31
Henriksen, G., Platzer, S., Marton, J., Hauser, A., Berthele, A., Schwaiger, M., Marinelli, L., Lavecchia, A., Novellino, E., & Wester, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0507274 · Cited by 35
Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats
Steinmiller, C. L., & Young, A. M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0898-5 · Cited by 31
“…of DPDPE effects may not reflect delta antagonist actions, however, as antagonism of DPDPE appeared noncompetitive in the hotplate assay (Kramer et al. 1989), and DPDPE effects in the tail-flick assay may be mediated via spinal mu opioid receptors (cf. Matthes et al. 1996; Sora et al. 1997).”
BackgroundNguyen, A. T., Marquez, P. V., Hamid, A., Kieffer, B. L., Friedman, T. C., & Lutfy, K. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.040 · Cited by 31
“In contrast, as expected, morphine failed to induce CPP in mice lacking the μ opioid receptor or in wild-type mice treated with β-FNA, provide further support that the rewarding action of morphine is mediated via the μ opioid receptor (Matthes et al., 1996; Nguyen et al., 2012).”
BackgroundMethodResultInfluentialSelf-citationLeck, K. J., Bartlett, S. E., Smith, M. T., Megirian, D., Holgate, J. Y., Powell, K. L., MATTHAEI, K. I., & Hendry, I. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.024 · Cited by 31
Nishio, K. (2012) · Oncology Reports · doi:10.3892/or.2012.1660 · Cited by 31
Role of different brain structures in the behavioural expression of WIN 55,212‐2 withdrawal in mice
Castañé, A., Maldonado, R. J., & Valverde, O. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705882 · Cited by 31
“An unbiased place-conditioning procedure was used to evaluate the rewarding properties of WIN 55,212-2, as previously reported (Matthes et al., 1996; Maldonado et al., 1997).”
MethodResultSelf-citationMa, Q., Allchorne, A. J., & Woolf, C. J. (1998) · Pain · doi:10.1016/s0304-3959(98)00081-5 · Cited by 34
“It is likely though, based on the null mutation of them receptor, that the primary action of morphine is via this and not thed or k receptors (Matthes et al., 1996).”
BackgroundRobertson, B., Schulte, G., Elde, R. P., & Grant, G. (1999) · European Journal of Pain · doi:10.1053/eujp.1998.0104 · Cited by 31
“As morphine appears to have the highest affinity for the µ-opioid receptor (Dickenson, 1994; Matthes et al., 1996), the loss of µ-opioid receptors in the dorsal horn could, in part, explain why the efficacy of opioid substances have been claimed to be weaker against neuropathic and, particulary,…”
BackgroundCoutens, B., & Ingram, S. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109408 · Cited by 35
“…subtypes and contributes to receptor desensitization and tolerance to opioid agonists; MOR (Arttamangkul et al., 2018; Miess et al., 2018; Schulz et al., 2004), DOR (Pei et al., 1995; Pradhan et al., 2016), KOR (Abraham et al., 2018; McLaughlin et al., 2004), and NOP (Thakker and Standifer, 2002).”
BackgroundWhy Do Birds Flock? A Role for Opioids in the Reinforcement of Gregarious Social Interactions
Riters, L. V., Kelm‐Nelson, C. A., & Spool, J. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00421 · Cited by 32
“Opioids that bind to mu opioid receptors are also well-known for their rewarding and analgesic properties (Matthes et al., 1996; Trescot et al., 2008; Jhou et al., 2012; Fields and Margolis, 2015).”
BackgroundDelineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor
Kelly, B., Hollingsworth, S. A., Blakemore, D. C., Owen, R. M., Storer, R. I., Swain, N. A., Aydın, D., Torella, R., Warmus, J. S., & Dror, R. O. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00585 · Cited by 30
Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
Gutridge, A. M., Chakraborty, S., Varga, B. R., Rhoda, E. S., French, A. R., Blaine, A. T., Royer, Q. H., Cui, H., Yuan, J., Cassell, R. J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764885 · Cited by 30
Doyle, G. A. R., Sheng, X. R., Lin, S. S. J., Press, D. M., Grice, D. E., Buono, R. J., Ferraro, T. N., & Berrettini, W. H. (2006) · Gene · doi:10.1016/j.gene.2006.10.017 · Cited by 30
Zhang, J., Song, C., Dai, J., Li, L., Yang, X., & Chen, Z. (2022) · MedComm · doi:10.1002/mco2.148 · Cited by 41
Billa, S. K., Xia, Y., & Morón, J. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07314.x · Cited by 33
“Although two DOPr subtypes (DOPr1 and DOPr2) have been identified (Jiang et al., 1991; Mattia et al., 1991; Sofuoglu et al., 1991), it has been reported that blockade of DOPr2 rather than DOPr1 may play an important role in the modulation of drug-induced behavior.”
BackgroundXie, Z., Li, Z., Guo, L., Ye, C., Li, J., Yu, X., Yang, H., Wang, Y., Chen, C., Zhang, D., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.005 · Cited by 32
“The μ opioid receptors mediate analgesia, respiratory depression, immunosuppression, decreased gastrointestinal transit, reward increased locomotor activity and dependence induced by morphine and other μpreferring compounds (Matthes et al., 1996).”
BackgroundDifferential responses to morphine-induced analgesia in the tail-flick test
Cecchi, M., Capriles, N., Watson, S. J., & Akil, H. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.034 · Cited by 31
Divergent modes for cargo-mediated control of clathrin-coated pit dynamics
Soohoo, A. L., & Puthenveedu, M. A. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-07-0550 · Cited by 38
Metadata
- Authors
- Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B. P., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Surrey (GB)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Inserm (FR)
- Venue
- Nature
- Published
- 1996-10
- Volume
- 383
- Issue
- 6603
- Pages
- 819-823
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051746492
- Cited by
- 1,722
- References
- 25
- Citations by year
- 2026: 36 · 2025: 40 · 2024: 45 · 2023: 52 · 2022: 53 · 2021: 56 · 2020: 59 · 2019: 56 · 2018: 53 · 2017: 43 · 2016: 59 · 2015: 53 · 2014: 60 · 2013: 65 · 2012: 58
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- mu-opioid receptor, morphine, analgesia, opioid reward, place preference, opioid withdrawal, physical dependence, knockout mice, delta opioid receptor, kappa opioid receptor, opioid system, pain management
- MeSH terms
- Analgesics, Animals, Behavior, Animal, Cell Line, Enkephalins, Mice, Inbred C57BL, Morphine, Morphine Dependence, Narcotics, Reward, Substance Withdrawal Syndrome, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.